Scores are 0 to 100 against every US stock we track; 50 is average. Recomputed after every US market close.
Fiscal year to December 2025, from the company's annual filing with the SEC.
| Salesyearly sales | $5.0B |
| Sales growthchange from the year before | +18.8% |
| Gross marginshare of sales left after the direct cost of what it sells | 20.1% |
| Operating marginshare of sales left after running the business | 8.5% |
| Net marginshare of sales kept as profit | 6.8% |
| Return on invested capitalprofit made on each $100 put into the business | 14.1% |
| Return on equityprofit vs. shareholders' accounting value | 15.4% |
| Debt / equitydebt vs. shareholders' accounting value | 0.06 |
| Change in share countnegative = the company is buying back its shares | +1.1% |
2 insiders sold $136K (all under pre-arranged plans) on the open market.
| Blouin Ann ScottDirector | Sold (plan)Jul 27 | 375 shat $183.54 · $69K |
| Agwunobi John ODirector | Sold (plan)Jul 20 | 392 shat $171.06 · $67K |
From Form 4 filings with the SEC. Open-market trades only. "Plan" = a sale set up in advance under a 10b5-1 plan, usually routine.
Not financial advice. Research and education only: the same view for everyone, with no regard to your circumstances. Past results do not predict future ones. Decide for yourself or with a licensed adviser. Terms · Privacy